Mefloquine plus sulfadoxine and pyrimethamine.
D000818:Animals; D004338:Drug Combinations; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D015767:Mefloquine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
D004338:Drug Combinations; D015767:Mefloquine; D011739:Pyrimethamine; D013413:Sulfadoxine; C046846:mefloquine-sulfadoxine-pyrimethamine; D000096926:Benzenesulfonamides